<DOC>
	<DOCNO>NCT00331578</DOCNO>
	<brief_summary>The trial aim evaluate 12-month long-term efficiency Excel stent treatment coronary heart disease inhibition restenosis coronary artery stenting well 12 month ' long-term safety cessation clopidogrel anti-platelet drug use 6 month implantation degradable drug coat stent .</brief_summary>
	<brief_title>Multi-Center Registry Trial EXCEL Biodegradable Polymer Drug-Eluting Stent</brief_title>
	<detailed_description />
	<mesh_term>Chlorhexidine</mesh_term>
	<mesh_term>Chlorhexidine gluconate</mesh_term>
	<criteria>1 . Patient full fill criterion use Excel stent . 2 . Each include patient allow use Excel stent . 3 . Complete revascularization achieve one invasive operation . 1 . Patient suitable use Excel stent , example , tolerant antiplatelet drug undergo cardiac/noncardiac surgery recently . 2 . Patient multiple branch lesion , thus single Excel stent resolve condition . 3 . NYH Cardiac functional grading &gt; 3 Echocardiography LVEF &lt; 0.3 . 4 . Patient complete revascularization resolve one operation .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2009</verification_date>
</DOC>